Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector
- 1 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 15 (6) , 985-990
- https://doi.org/10.1097/00001756-200404290-00011
Abstract
Vectors based on lentiviruses are opening up new approaches for the treatment of neurodegenerative diseases. Currently, the equine infectious anaemia virus (EIAV) vector is one of the most attractive gene delivery systems with respect to neuronal tropism. The aim was to validate EIAV-lentiviral vectors as a gene delivery system for neurotrophic factor genes in an animal model of Parkinson's disease. EIAV carrying the glial cell line-derived neurotrophic factor (GDNF) gene was unilaterally injected into rat striatum and above the substantia nigra (SN). One week later, the rats received a 6-OHDA lesion into the ipsilateral striatum. GDNF delivery led to extensive expression of GDNF protein within the striatum. In addition, near complete protection against dopaminergic cell death was observed in the GDNF-treated group.Keywords
This publication has 23 references indexed in Scilit:
- A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cellsNature, 2003
- Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressinMolecular Therapy, 2003
- Viral vectors for gene delivery to the nervous systemNature Reviews Neuroscience, 2003
- Multicistronic Lentiviral Vector-Mediated Striatal Gene Transfer of Aromatic l-Amino Acid Decarboxylase, Tyrosine Hydroxylase, and GTP Cyclohydrolase I Induces Sustained Transgene Expression, Dopamine Production, and Functional Improvement in a Rat Model of Parkinson's Disease.Journal of Neuroscience, 2002
- [27] Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectorsPublished by Elsevier ,2002
- Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral deliveryHuman Molecular Genetics, 2001
- Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNFExperimental Neurology, 2000
- Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's DiseaseHuman Gene Therapy, 2000
- Viral vectors, tools for gene transfer in the nervous systemProgress in Neurobiology, 1998
- Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Proceedings of the National Academy of Sciences, 1996